BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1561 related articles for article (PubMed ID: 34739716)

  • 1. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
    Luxi N; Giovanazzi A; Capuano A; Crisafulli S; Cutroneo PM; Fantini MP; Ferrajolo C; Moretti U; Poluzzi E; Raschi E; Ravaldi C; Reno C; Tuccori M; Vannacci A; Zanoni G; Trifirò G;
    Drug Saf; 2021 Dec; 44(12):1247-1269. PubMed ID: 34739716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy.
    Gloeckner S; Hornung F; Heimann Y; Schleussner E; Deinhardt-Emmer S; Loeffler B; Zoellkau J
    Am J Obstet Gynecol; 2022 Feb; 226(2):261-262. PubMed ID: 34648744
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine.
    Kuan AS; Chen SP; Wang YF; Wang SJ
    Cephalalgia; 2023 Oct; 43(10):3331024231208110. PubMed ID: 37851648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.
    Spadaccini M; Canziani L; Aghemo A; Lleo A; Maselli R; Anderloni A; Carrara S; Fugazza A; Pellegatta G; Galtieri PA; Hassan C; Greenwald D; Pochapin M; Wallace M; Sharma P; Roesch T; Bhandari P; Emura F; Raju GS; Repici A
    United European Gastroenterol J; 2021 Sep; 9(7):787-796. PubMed ID: 34102015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.
    Cerqueira-Silva T; Andrews JR; Boaventura VS; Ranzani OT; de Araújo Oliveira V; Paixão ES; Júnior JB; Machado TM; Hitchings MDT; Dorion M; Lind ML; Penna GO; Cummings DAT; Dean NE; Werneck GL; Pearce N; Barreto ML; Ko AI; Croda J; Barral-Netto M
    Lancet Infect Dis; 2022 Jun; 22(6):791-801. PubMed ID: 35366959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Magnus MC; Håberg SE; Carlsen EØ; Kwong JC; Buchan SA; Fell DB
    Clin Infect Dis; 2023 Jan; 76(1):57-65. PubMed ID: 36071540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
    Alexander JL; Moran GW; Gaya DR; Raine T; Hart A; Kennedy NA; Lindsay JO; MacDonald J; Segal JP; Sebastian S; Selinger CP; Parkes M; Smith PJ; Dhar A; Subramanian S; Arasaradnam R; Lamb CA; Ahmad T; Lees CW; Dobson L; Wakeman R; Iqbal TH; Arnott I; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):218-224. PubMed ID: 33508241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Feikin DR; Higdon MM; Abu-Raddad LJ; Andrews N; Araos R; Goldberg Y; Groome MJ; Huppert A; O'Brien KL; Smith PG; Wilder-Smith A; Zeger S; Deloria Knoll M; Patel MK
    Lancet; 2022 Mar; 399(10328):924-944. PubMed ID: 35202601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
    Izmirly PM; Kim MY; Samanovic M; Fernandez-Ruiz R; Ohana S; Deonaraine KK; Engel AJ; Masson M; Xie X; Cornelius AR; Herati RS; Haberman RH; Scher JU; Guttmann A; Blank RB; Plotz B; Haj-Ali M; Banbury B; Stream S; Hasan G; Ho G; Rackoff P; Blazer AD; Tseng CE; Belmont HM; Saxena A; Mulligan MJ; Clancy RM; Buyon JP
    Arthritis Rheumatol; 2022 Feb; 74(2):284-294. PubMed ID: 34347939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.
    Nicolaidou V; Georgiou R; Christofidou M; Felekkis K; Pieri M; Papaneophytou C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
    Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
    Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.
    Wei J; Zhang W; Doherty M; Wallace ZS; Sparks JA; Lu N; Li X; Zeng C; Lei G; Zhang Y
    BMC Med; 2023 Feb; 21(1):78. PubMed ID: 36855108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations.
    Kantarcioglu B; Iqbal O; Lewis J; Carter CA; Singh M; Lievano F; Ligocki M; Jeske W; Adiguzel C; Gerotziafas GT; Fareed J
    Clin Appl Thromb Hemost; 2022; 28():10760296211056648. PubMed ID: 35167393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19.
    Cha HH; Lim SY; Kwon JS; Kim JY; Bae S; Jung J; Kim SH
    Korean J Intern Med; 2022 Mar; 37(2):455-459. PubMed ID: 35272444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overview of COVID-19 vaccines licensed in the EU-from technology via clinical trial to registration].
    Hildt E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Dec; 65(12):1237-1243. PubMed ID: 36257986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.